Skip to content

Legislative Life Sciences Caucus

Life Sciences Caucus Documents

2023 Meetings

2022 Meetings

June 28, 2022 Rare Diseases and Gene Therapy

Gene therapy and rare diseases topic of Life Sciences Caucus

The General Assembly's Life Sciences Caucus met Tuesday, June 28, to learn about the promise of gene therapies as potential treatments for rare diseases.

Nearly two dozen legislators and staff members heard from Priya Kishnani, M.D., and Vandana Shashi, M.D., of the Duke Undiagnosed Diseases Network and Marianne Hamilton Lopez, M.D., of the Duke Margolis Center for Health Policy along with Charlene Cowell, executive director of Bleeding Disorders of North Carolina. Caucus Co-Chairs Sen. Paul Newton, Sen. Mike Woodard and Rep. Donna White were in attendance.

Hamilton Lopez told legislators that gene therapies will often differ from traditional treatment in that the therapies may only be administered once as opposed to conventional treatments that are given as multiple or continual doses of medication. Gene therapies are currently much more expensive than conventional therapies, which makes them a challenge for our current system to pay. The upfront cost of these breakthrough therapies must be weighed against the impressive benefits they offer compared to conventional therapies.


Story of Wade Hosey, child with spinal muscular atrophy

Sen. Paul Newton and Rep. Donna White, Life Science Caucus Meeting, June 27 2022

Caucus Co-Chairs Sen. Paul Newton and Rep. Donna White

Caucus Co-Chair Sen. Mike Woodard

Caucus Co-Chair Sen. Mike Woodard

Life Sciences Caucus Meeting, June 27, 2022

Feb. 23, 2022 Tour of NC Reseach Campus

2021 Meetings

2020 Meetings

October 19, 2020 Virtual Meeting
September 14, 2020 Virtual Meeting
May 19, 2020 Virtual Meeting
March 10, 2020 Lee County Tour
February 3, 2020 Johnston County Tour

2019 Meetings

2018 Meetings

NC Life Sciences Headlines

United Therapeutics to build $500 million manufacturing facility in RTP

W-S cellular therapeutics company plans 330 new jobs, plant in Triad

Drug giant Merck, NC A&T to launch biotech training center

United Therapeutics opens a net zero energy center in RTP

IQVIA raises $1.25 billion in upsized offering

NC firms ink billion-dollar deal to discover new treatments

Custom surgical implant startup lands $12 million in new cash

Big cash infusion to boost Durham startup 410 Medical’s critical care efforts

NC Biotech Center hands out early $2.3 million in grants, loans

Duke spin-out scores $2 million to forward diagnostics platform

Winston-Salem's Innovation Quarter economic impact reaches $1.66 billion in 2022

Bioengineering firm raises up to $150 million in new capital

Raleigh startup raises $36 million to advance COPD treatment

Hatteras-backed startup aims to treat 'undruggable' cancer targets

NC pharma startup raises $15 million to fight anaphylaxis without needles

RTP drug developer adds $30 million to extend cash runway

Life sciences firm relocates headquarters to downtown Raleigh

Global CRO opens new office in Wilmington

Small pharma firm raises $15 million to treat lung disease

Raleigh pharma raises $5 million as phase 3 study begins

Dignify Therapeutics lands federal grant to drive bladder, bowel treatment

Biotech Tiamat Sciences adds $2 million to seed round

Wilmington clinical research firms lands NIH contract for neurological device development
Biotech with office in Chapel Hill closes on $65 million funding round

Neonatal care startup lands nearly $16 million in new round of financing

NCBiotech awards $2.3 million in mix of 19 grants, loans

Nanotech startup pursing new drug delivery technology is raising $2 million

New Triangle pharma raises $150 million for thyroid drug

Triangle precision medicine, drug research firm lands $25 million in new capital

Eli Lilly to expand Durham campus with 100-job manufacturing facility

Pfizer expands North Carolina manufacturing footprint with plant purchase

Labcorp clinical-trials spinoff expected to employ 19,000 workers

Winston-Salem regenerative medicine community launches clinical trials program

Freight forwarder DHL makes $8 million bet on Triangle pharma

NC’s booming life science sector now pays average wage of $112,000

$60 million startup aims to redefine treatment of severe neuropsychiatric disorders

Pharma packaging maker to create 80 jobs, invest $20 million in Winston-Salem

Triangle lands R&D center for Iowa company developing animal vaccines